JB Pritzker Lost 80 Pounds on GLP-1 Drugs Covered for Illinois Workers
Left 50%
Center 0%
Right 50%
1 left · 0 center · 1 right
What happened
Illinois Gov. JB Pritzker said in a CBS Mornings interview that aired Monday that he has used a GLP-1 medication for about two years after a diabetes diagnosis and has lost 80 pounds. He said he injects the drug weekly, walks nearly four miles along Lake Michigan most mornings, is no longer on insulin, and cited a family history that includes his father Donald’s fatal heart attack at 39; Pritzker said he had been overweight since about age 7 or 8. In July 2024 his administration expanded state-employee insurance to cover GLP-1s for weight loss as well as diabetes for about 55,000 workers, a change the Chicago Sun-Times reported cost Illinois $147 million in fiscal year 2025—below an initial office estimate of $210 million that some economists said could run three times higher, with individual prescriptions costing more than $16,000 a year. Pritzker, who is seeking a third term and has been discussed as a possible 2028 Democratic presidential candidate, said the coverage will save money by reducing diabetes and other disease; asked whether a White House bid factored into the weight loss, he said he has made no decisions about his future and is “focused on what’s best for the people of Illinois.” During the 2024 campaign, Donald Trump had said Pritzker “wants to eat all the time.”
Sourcing check · Mostly on the record · 2 articles
1 of 2 articles cite a named source for the story. It was on the record from the first report.
What these terms mean and how they're counted
- On the record · names a source 1 of 2
- On the record means the article cites a source by name for the story's main claim: a person, or an institution speaking officially, such as a company statement or a named agency's spokesperson. The opposite is an unnamed source. The count is how many of the counted articles cite at least one such source; the names are everyone named across them, each once however the articles spell it. Here: JB Pritzker
- Primary evidence · cites a document or data 0 of 2
- Primary evidence means the article cites a record you could check yourself: a court filing or ruling, a dataset or report, a recording or transcript, an official statement or press release, market data. A quote is not a document. The count is how many articles cite one. Here: None cited.
- Credits another outlet 0 of 2
- The article says the story comes from another outlet's reporting (“first reported by Reuters”). Those articles relay the story; they are not independent confirmation. Here: Each article presents its own reporting.
- Unnamed sources 0 of 2
- The main claim is attributed to people who are not identified: “people familiar with the matter”, “officials said”. The count is how many articles do this.
- How it developed
- When the first report landed and whether it named anyone; when the first named source and the first document appeared. Here: First report Sep 22, 01:24 UTC by Breitbart, naming its source.
- Not counted 0
- Opinion, analysis and video pieces, and articles too short to assess. Every count above is out of the counted articles. An article republished under a new headline is one article.
This is about who is cited, not whether the story is true. Each source below says what it names. How we count
Omitted — what each side leaves out
Unpacked
Left-leaning coverage treats Governor Pritzker's interview as a personal health reveal and skips the policy half, in which he said Illinois now covers GLP-1s for 55,000 state employees. Right-leaning coverage reports that expanding that coverage beyond diabetes patients cost $147 million in the first fiscal year. A reader of The New York Times or The Hill would not know he used that same appearance to defend the policy and claim it will save money because fewer people will develop diabetes.
Right-leaning coverage headlines the story as one in which "Taxpayers Cover State Workers' Access." Left-leaning coverage headlines the pounds lost and a possible White House bid.
None of the coverage answers whether Pritzker is enrolled in the state plan that pays for the drugs.
Bottom line
The New York Times covered Pritzker's GLP-1 reveal as a personal story and left out the $147 million state benefit he promoted in the same sitting.
The receipts — 4 facts one side's coverage lacks
- The coverage expansion cost Illinois $147 million in fiscal year 2025
- Pritzker's office had initially estimated $210 million for the first full year
- Individual prescriptions cost more than $16,000 a year
- The governor had dodged questions about his weight loss for the past year before the disclosure
The Left View
Left-leaning outlets treated the interview chiefly as a personal health disclosure by a governor “widely seen as a potential presidential candidate,” foregrounding his line that he has “been driven my whole life to lose weight” and that the drug made that possible. They centered the medical sequence—the diagnosis, his doctor’s recommendation, his wife’s encouragement given family history, and his description of the regimen as “life-changing”—and his claim that covering the drugs for state workers will save money because fewer people will develop diabetes. They did not dwell on program cost or on how long he had declined to discuss his appearance.
The Right View
Right-leaning coverage framed the same interview as a taxpayer story: the governor disclosed his own use in the appearance where he noted that the state covers the drugs for those 55,000 employees. Breitbart highlighted the $147 million fiscal 2025 outlay, the higher initial estimate, economist projections that costs could run three times higher, and prescriptions above $16,000 a year. It stressed that he had “dodged questions about his weight loss for the past year,” that he wants to use his gubernatorial platform to promote the drug, and that he would not separate a possible 2028 run from the transformation, against the backdrop of Trump’s 2024 remarks.
Our Take (balanced)
The left’s strongest argument is medical necessity plus prevention: the diabetes diagnosis, family cardiac history, and exit from insulin give a concrete patient case, and Pritzker argues coverage pays for itself by averting diabetes and related disease—a claim he tied to a constituent who told him the initiative “saved her life.” The right’s strongest argument is cost and political timing: a nine-figure expansion whose first-year bill already hit $147 million, with higher forecasts on the record, was sold as savings while the governor, after a year of avoiding the subject, went public and offered to evangelize the drug from office amid 2028 speculation. The unresolved tension is whether the disclosure and the benefit expansion are best read as a governor using his own results to advertise a cost-offsetting public-health policy, or as a high-cost entitlement whose messenger is also a politician managing his image.
4 sources
More stories
The week's bottom lines, in your inbox
One email a week: the five stories that mattered and what they actually mean. Free.